- Report
- June 2024
- 209 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- October 2024
- 189 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2024
- 141 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- February 2025
- 120 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- January 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- November 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 170 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- November 2024
- 110 Pages
United States
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2022
- 197 Pages
Global
From €6445EUR$6,780USD£5,415GBP
- Report
- August 2022
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4706EUR$4,950USD£3,953GBP
Ulcerative Colitis (UC) is a type of Inflammatory Bowel Disease (IBD) that affects the large intestine. It is characterized by inflammation and ulceration of the inner lining of the colon and rectum. Symptoms of UC include abdominal pain, bloody diarrhea, fatigue, and weight loss. Treatment options for UC include medications, lifestyle changes, and surgery.
The UC market is a subset of the larger Gastroenterology market. It is a growing market, driven by an increasing prevalence of IBD and the development of new treatments. The market is highly competitive, with a number of companies offering treatments for UC.
Some of the companies in the UC market include AbbVie, Allergan, AstraZeneca, Janssen, Pfizer, and Takeda. Show Less Read more
